Navigation Links
Buckfire & Buckfire, P.C. Dangerous Drug Lawyers Now Accepting Michigan Actos Lawsuits
Date:6/10/2013

Southfield, MI (PRWEB) June 11, 2013

The dangerous drug legal team at the personal injury law firm of Buckfire & Buckfire, P.C. is now actively accepting Actos lawsuits for those patients allegedly suffering serious injuries after taking the prescribed diabetes drug. The dangerous drug lawyers are accepting all cases that involve patients who have been diagnosed with bladder cancer while taking Actos or within five years of their Actos usage.

Actos, also known as a pioglitazone, is a drug that is prescribed for treatment of diabetes, particularly Type 2 diabetes. However, even though Actos is known to be an effective drug in treating this medical condition, the drug has also been allegedly linked to bladder cancer. In fact, on June 15, 2011 the FDA have warned patients that the drug Actos may be associated with developing bladder cancer. (Click here to view the FDA Drug Safety Communication report on Actos).

Patients allegedly suffering from bladder after taking the drug Actos do have legal rights and may have a possible Actos lawsuit against the drug manufacturer, Takeda Pharmaceutical. These cases seek fair compensation to patients who have been allegedly harmed by the medication that was prescribed to them by their physicians.

“There are strict statute of limitations for filing a Michigan Actos lawsuit. If you miss a deadline your case will be lost forever. It is important when choosing your lawyer for your bladder cancer Actos case that you choose an attorney that has significant experience in dangerous drug cases and representing patients injured or harmed by a dangerous drug. At the law firm of Buckfire & Buckfire, P.C. our Michigan Actos lawyers work directly with other national law firms to win the best settlement for our clients,” says Partner and Attorney Lawrence J. Buckfire.

Patients taking Actos and their physicians should be fully aware of the alleged potential association between Actos and bladder cancer, as well as other side effects of the drug.

ABOUT BUCKFIRE & BUCKFIRE, P.C.

Buckfire & Buckfire, P.C. is a family-owned Michigan personal injury law firm representing patients who have been diagnosed with bladder cancer or allegedly suffering from bladder cancer during their Actos diabetes drug usage. Patients harmed do have legal rights and there may be legal ground to pursue a lawsuit. The Michigan Actos lawyers at the award winning law firm offers a free no obligation consultation and has a No Win No Fee guarantee, meaning there are no legal fees or costs until your case is settled or won.

To learn more about the Michigan Actos lawyers at Buckfire & Buckfire, P.C. call toll-free at (800) 606-1717 or visit the law firm website at http://www.BuckfireLaw.com

To view a recent video by the Buckfire & Buckfire, P.C. law firm on their active representation of Actos lawsuits visit http://youtu.be/B9gcYFzcfDg

Read the full story at http://www.prweb.com/releases/2013/6/prweb10813883.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Buckfire & Buckfire, P.C. Accident Attorneys Announce New Ugly Christmas Sweater Social Media Contest
2. Slip and Fall Accident Attorney At Buckfire & Buckfire, P.C. Makes Michigan Lawyers Weekly For Fall on Ice Settlement
3. Buckfire & Buckfire Motorcycle Attorney Meets with Legislators on Issues Affecting Injured Motorcyclists
4. Michigan Car Accident Attorneys at Buckfire & Buckfire, P.C. Sponsor Gala for Spinal Cord Injury Victims
5. Michigan Bike Accident Lawyers at Buckfire & Buckfire Celebrate Bicycle Helmet Safety Week
6. Michigan Car Accident Lawyer at Buckfire & Buckfire, P.C. Creates Drunk Driving Deaths Infographic
7. Buckfire & Buckfire, P.C. Dog Bite Lawyers in Michigan Discuss National Dog Bite Prevention Week
8. Buckfire & Buckfire, P.C. Michigan Hip Replacement Lawyers Now Accepting Stryker Hip Implant Lawsuits
9. Buckfire & Buckfire, P.C. Lawyers Now Accepting Michigan Mirena IUD Lawsuits
10. Research shows efficacy of treatment model developed at Women & Infants
11. Soy-based S-equol supplement reduces hot flash frequency, muscle & joint pain in US women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , ... March 23, 2017 , ... ... services to their communities, 16 more public health departments have been awarded national ... bring another 4.5 million people into the expanding network of communities across the ...
(Date:3/23/2017)... ... 23, 2017 , ... The IoT (Internet of Things) is revolutionizing the way ... impact on businesses and individual consumers alike. Laboratories can maximize their profit margin ... anywhere from $4 trillion to $11 trillion dollars by the year 2025. McKinsey expects ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... businesses of the Norwalk and Vermillion areas, celebrates the newest charity campaign ... a nonprofit, community-based substance abuse prevention and peer recovery support organization providing ...
(Date:3/23/2017)... ... 23, 2017 , ... The StayWell Company announced today that ... covers StayWell’s asthma, coronary artery disease, congestive heart failure, chronic obstructive pulmonary disease, ... excellent programs for the delivery and improvement of disease management and that meet ...
(Date:3/23/2017)... ... March 23, 2017 , ... The TouchPoint Solution, home of Buzzies ... stress and anxiety. , “Buzzies change the way we interact with stress and ... , Since its launch date in December 2016, The TouchPoint Solution has sold more ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , March 23, 2017  Mirabilis Medical, a ... medical technology for non-invasive surgery, announced today CE ... for treatment of uterine fibroids throughout the European ... received approval from the US Food and Drug ... Mirabilis System in the United States.  The Mirabilis ...
(Date:3/24/2017)... , March 24, 2017 ... to develop sutezolid as effective response to infectious disease ... Alliance and the Medicines Patent Pool (MPP) announced a ... antibiotic drug candidate which demonstrated encouraging results in early ... in combination with other TB drugs and follows the ...
(Date:3/23/2017)... 2017 Research and Markets has announced the ... Industry Forecast to 2025" report to their offering. ... The Global Cryostat Market ... the next decade to reach approximately $3.5 billion by 2025. ... all the given segments on global as well as regional levels ...
Breaking Medicine Technology: